Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs GM-CSF-transduced tumour cell vaccine (Primary) ; Celecoxib; Cyclophosphamide
- Indications Malignant thymoma; Mesothelioma; Non-small cell lung cancer; Oesophageal cancer; Small cell lung cancer; Thymoma
- Focus Adverse reactions
Most Recent Events
- 03 Mar 2020 Biomarkers information updated
- 17 Jun 2010 New trial record